Concepedia

Author

Fangfang Bi

China Medical UniversityORCID

Also Known As

Bi F, Bi, Fangfang, F Bi, Fang-Fang Bi, Fangfang Bi, Fang‐Fang Bi, Feng Bi

59

Publications

1.3K

Citations

22

H-Index

57

Concepts

All Affiliations

China Medical UniversityChinese Academy of Medical Sciences & Peking Union Medical CollegeYale UniversityChinese PLA General HospitalSheng Jing Hospital
FB

About

Fangfang Bi is an author at China Medical University specializing in medicine, ovarian cancer, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

324

2

Natural Sciences

1

1

11

3

Public Health

1

1

10

4

Social Sciences

1

1

25

5

Allergy

1

1

17

Fangfang Bi

×

38

Publications

1.3K

Citations

22

H-Index

YearCitations

Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer

Fangfang Bi, Ying Chen, Qing Yang

Cancer Cell International

2020

116

Autophagy is activated in the ovarian tissue of polycystic ovary syndrome

Da Li, Yue You, Fangfang Bi,

Reproduction

2017

96

Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA

Min Kang, Bo Tang, Jixi Li,

Molecular Cancer

2020

93

Evaluation of the efficacy of laparoscopic resection for the management of exogenous cesarean scar pregnancy

Guangwei Wang, Xiaofei Liu, Fangfang Bi,

Fertility and Sterility

2014

85

Development of a Novel Autophagy-related Prognostic Signature for Serous Ovarian Cancer

Yuanyuan An, Fangfang Bi, Yue You,

Journal of Cancer

2018

78

TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway

Tianshui Sun, Fangfang Bi, Zhuonan Liu,

Journal of Translational Medicine

2021

66

Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2

Tianshui Sun, Zhuonan Liu, Fangfang Bi,

Molecular Oncology

2021

65

Identification of pathological grade and prognosis‐associated lncRNA for ovarian cancer

Ying Chen, Fangfang Bi, Yuanyuan An,

Journal of Cellular Biochemistry

2019

54

Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment

Jianlei Bi, Fangfang Bi, Xue Pan,

Journal of Translational Medicine

2021

54

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer

Tianshui Sun, Fangfang Bi, Zhuonan Liu,

Aging

2020

36

Page 1